Who We Are

Our Mission

As a startup enterprise, Eureka Biotech is committed to advancing organoid technology to produce top-tier brain and heart organoids, specifically designed for drug screening applications. Our second mission centers around harnessing stem cell technology to develop factory-cultured meat, ensuring a secure protein source, particularly in the face of potential oceanic pollution.

Eureka Biotech takes pride in its robust technical foundation, validated through rigorous peer-reviewed publications and fortified by a portfolio of American patents. We enthusiastically invite collaboration opportunities to expedite translational research and propel us toward commercial success.

Advancing Biomedical Discovery

Eureka Biotech Inc, a subsidiary of Eureka International Group with robust financial backing, is strategically located in the heart of University City, Philadelphia, adjacent to the University of Pennsylvania and Drexel University. Our state-of-the-art facilities are poised to meet the demands of both biological and engineering research, and we extend our expertise to international clients seeking FDA approval within the United States.

Eureka Biotech Achieves Third Place at Eureka IIEC 2024 for Human iPSC Artificial Skin

Pioneering Stem Cell & Organoid Innovations